Macquarie Group’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252K | Hold |
70,000
| – | – | ﹤0.01% | 1524 |
|
|
2025
Q1 | $209K | Hold |
70,000
| – | – | ﹤0.01% | 1533 |
|
|
2024
Q4 | $235K | Hold |
70,000
| – | – | ﹤0.01% | 1501 |
|
|
2024
Q3 | $235K | Hold |
70,000
| – | – | ﹤0.01% | 1543 |
|
|
2024
Q2 | $232K | Hold |
70,000
| – | – | ﹤0.01% | 1547 |
|
|
2024
Q1 | $283K | Hold |
70,000
| – | – | ﹤0.01% | 1497 |
|
|
2023
Q4 | $214K | Hold |
70,000
| – | – | ﹤0.01% | 1539 |
|
|
2023
Q3 | $210K | Hold |
70,000
| – | – | ﹤0.01% | 1521 |
|
|
2023
Q2 | $262K | Hold |
70,000
| – | – | ﹤0.01% | 1520 |
|
|
2023
Q1 | $235K | Hold |
70,000
| – | – | ﹤0.01% | 1535 |
|
|
2022
Q4 | $337K | Sell |
70,000
-1,504
| -2% | -$7.24K | ﹤0.01% | 1557 |
|
|
2022
Q3 | $407K | Hold |
71,504
| – | – | ﹤0.01% | 1550 |
|
|
2022
Q2 | $508K | Hold |
71,504
| – | – | ﹤0.01% | 1589 |
|
|
2022
Q1 | $516 | Hold |
71,504
| – | – | ﹤0.01% | 1640 |
|
|
2021
Q4 | $639K | Buy |
71,504
+70,000
| +4,654% | +$626K | ﹤0.01% | 1630 |
|
|
2021
Q3 | $53K | Buy |
+1,504
| New | +$53K | ﹤0.01% | 2204 |
|